A clinical study assessing safety of the BNT162b2 mRNA Covid-19 Vaccine
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 17 Sep 2021 New trial record
- 25 Aug 2021 Results published in the New England Journal of Medicine